<DOC>
	<DOCNO>NCT02468089</DOCNO>
	<brief_summary>A Minimum 150 consecutive patient decompensated cirrhosis etiology , present Institute Liver Biliary Sciences hospital diagnosis difficult treat SBP include randomize two treatment group . Group A - Carbepenem+albumin Group B - Carbepenem+albumin+GMCSF .</brief_summary>
	<brief_title>To Compare Efficacy Carbepenem Versus Carbepenem Plus GM-CSF Difficult To Treat Spontaneous Bacterial Peritonitis</brief_title>
	<detailed_description />
	<mesh_term>Peritonitis</mesh_term>
	<criteria>1 . Age 18 year 2 . Patients decompensated liver cirrhosis present Spontaneous bacterial peritonitis ( Presence 250 neutrophil per cc ascetic fluid , absence surgical abdomen , presence decompensated cirrhosis portal hypertension ) respond initial therapy DTTSBP : Hospital acquire New onset SBP ( Spontaneous bacterial peritonitis ) 48 h hospitalization . Recurrent SBP One prior episode ( ) SBP year . Antibiotic resistant Resistance 3rd Gen Cephalosporin last 3 m. Antibiotic nonresponse Nonresponse 3rd Gen Cephalosporin , sepsis 3rd Gen Cephalosporin . 1 . &lt; 18 year . 2 . Advanced HCC ( HepatoCellular Carcinoma ) 3 . Post liver transplant 4 . HIV + , Immunosuppressive therapy 5 . Pregnancy 6 . Domiciliary treatment 7 . No consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>